 |
| Ligand ID: DSF Drugbank ID: DB01189(Desflurane) Indication:For use as an inhalation agent for induction and/or maintenance of anesthesia for inpatient and outpatient surgery in adults. |
| DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
|---|---|---|---|---|---|---|---|---|---|---|
 Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_C_DSFC320_1 (GLR4197 PROTEIN) | 2ajf | SPIKE PROTEIN (SARSr-CoV) | 4 / 8 | TYR F 410ILE F 397ILE F 405VAL F 496 | 1.03A | 18.38 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_A_DSFA319_1 (GLR4197 PROTEIN) | 2cjr | NUCLEOCAPSID PROTEIN (SARS-COVTW1) | 5 / 9 | ILE F 358ILE E 321TYR E 334THR E 333ILE F 338 | 1.76A | 15.97 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_C_DSFC320_1 (GLR4197 PROTEIN) | 2cme | HYPOTHETICAL PROTEIN5 (SARSr) | 4 / 8 | PRO H 40VAL G 42THR H 23ILE H 24 | 1.34A | 14.29 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_C_DSFC320_1 (GLR4197 PROTEIN) | 2dd8 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 8 | TYR S 410ILE S 397ILE S 405VAL S 496 | 1.03A | 19.62 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_A_DSFA319_1 (GLR4197 PROTEIN) | 2dd8 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 9 | TYR S 410ILE S 397ILE S 405VAL S 496TYR S 481 | 1.76A | 19.62 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_C_DSFC320_1 (GLR4197 PROTEIN) | 2ghw | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 8 | TYR C 410ILE C 397ILE C 405VAL C 496 | 1.02A | 20.00 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_B_DSFB319_1 (GLR4197 PROTEIN) | 2h85 | PUTATIVE ORF1ABPOLYPROTEIN (SARSr-CoV) | 5 / 9 | PRO A 343ILE A 322ILE A 295VAL A 320ILE A 305 | 1.35A | 22.99 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_D_DSFD319_1 (GLR4197 PROTEIN) | 2h85 | PUTATIVE ORF1ABPOLYPROTEIN (SARSr-CoV) | 5 / 10 | PRO A 343ILE A 322ILE A 295VAL A 320ILE A 305 | 1.36A | 22.99 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_D_DSFD319_1 (GLR4197 PROTEIN) | 2jzd | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 10 | ILE A 560ILE A 556MET A 557TYR A 583ILE A 569 | 1.43A | 19.31 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_B_DSFB319_1 (GLR4197 PROTEIN) | 2kqv | NSP3 (SARSr-CoV) | 5 / 9 | TYR A 61ILE A 27MET A 35ILE A 47ILE A 45 | 1.71A | 19.88 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_D_DSFD319_1 (GLR4197 PROTEIN) | 2kqv | NSP3 (SARSr-CoV) | 5 / 10 | ILE A 34MET A 84VAL A 31TYR A 61ILE A 86 | 1.70A | 19.88 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_B_DSFB319_1 (GLR4197 PROTEIN) | 2ozk | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 5 / 9 | TYR A 193ILE A 305VAL A 320ILE A 295ILE A 327 | 1.70A | 23.56 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_D_DSFD319_1 (GLR4197 PROTEIN) | 2ozk | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 5 / 10 | TYR A 193ILE A 305VAL A 320ILE A 295ILE A 327 | 1.70A | 23.56 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_D_DSFD319_1 (GLR4197 PROTEIN) | 2rhb | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 5 / 10 | PRO E 343ILE E 322ILE E 295VAL E 320ILE E 305 | 1.17A | 23.56 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_B_DSFB319_1 (GLR4197 PROTEIN) | 2rhb | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 5 / 9 | PRO E 343ILE E 322ILE E 295VAL E 320ILE E 305 | 1.16A | 23.56 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_D_DSFD319_1 (GLR4197 PROTEIN) | 2rnk | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 10 | ILE A 560ILE A 556MET A 557TYR A 583ILE A 569 | 1.66A | 20.27 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_D_DSFD319_1 (GLR4197 PROTEIN) | 2wct | NSP3 (SARSr-CoV) | 5 / 10 | ILE C 560ILE C 556MET C 557TYR C 583ILE C 569 | 1.58A | 21.78 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_C_DSFC320_1 (GLR4197 PROTEIN) | 3bgf | SPIKE PROTEIN S1 (SARSr-CoV) | 4 / 8 | TYR S 410ILE S 397ILE S 405VAL S 496 | 1.07A | 20.07 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_C_DSFC320_1 (GLR4197 PROTEIN) | 3d0g | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 8 | TYR F 410ILE F 397ILE F 405VAL F 496 | 1.03A | 18.69 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_A_DSFA319_1 (GLR4197 PROTEIN) | 3d0g | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 9 | TYR F 410ILE F 397ILE F 405VAL F 496TYR F 481 | 1.73A | 18.69 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_A_DSFA319_1 (GLR4197 PROTEIN) | 3d0h | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 9 | TYR E 481TYR E 440ILE E 405VAL E 389TYR E 491 | 1.74A | 18.69 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_C_DSFC320_1 (GLR4197 PROTEIN) | 3d0h | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 8 | TYR F 410ILE F 397ILE F 405VAL F 496 | 1.08A | 18.69 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_C_DSFC320_1 (GLR4197 PROTEIN) | 3d0i | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 8 | TYR F 410ILE F 397ILE F 405VAL F 496 | 1.08A | 19.00 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_A_DSFA319_1 (GLR4197 PROTEIN) | 3d0i | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 9 | TYR E 481TYR E 440ILE E 405VAL E 389TYR E 491 | 1.77A | 19.00 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_A_DSFA319_1 (GLR4197 PROTEIN) | 3sci | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 9 | TYR E 410ILE E 397ILE E 405VAL E 496TYR E 481 | 1.77A | 21.38 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_C_DSFC320_1 (GLR4197 PROTEIN) | 3sci | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 8 | TYR F 410ILE F 397ILE F 405VAL F 496 | 1.03A | 21.38 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_A_DSFA319_1 (GLR4197 PROTEIN) | 3scj | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 9 | TYR E 410ILE E 397ILE E 405VAL E 496TYR E 481 | 1.76A | 18.67 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_C_DSFC320_1 (GLR4197 PROTEIN) | 3scj | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 8 | TYR F 410ILE F 397ILE F 405VAL F 496 | 0.98A | 18.67 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_A_DSFA319_1 (GLR4197 PROTEIN) | 3sck | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 9 | TYR E 481TYR E 440ILE E 405VAL E 389TYR E 491 | 1.74A | 18.99 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_C_DSFC320_1 (GLR4197 PROTEIN) | 3sck | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 8 | TYR F 410ILE F 397ILE F 405VAL F 496 | 1.06A | 18.99 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_C_DSFC320_1 (GLR4197 PROTEIN) | 3scl | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 8 | TYR F 410ILE F 397ILE F 405VAL F 496 | 1.02A | 18.67 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_A_DSFA319_1 (GLR4197 PROTEIN) | 3scl | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 9 | TYR F 410ILE F 397ILE F 405VAL F 496TYR F 481 | 1.72A | 18.67 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_B_DSFB319_1 (GLR4197 PROTEIN) | 4mm3 | UBIQUITIN (Homosapiens) | 5 / 9 | ILE A 30ILE A 36VAL A 5THR A 7ILE A 13 | 1.54A | 13.17 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_D_DSFD319_1 (GLR4197 PROTEIN) | 4mm3 | UBIQUITIN (Homosapiens) | 5 / 10 | ILE A 30ILE A 36VAL A 5THR A 7ILE A 13 | 1.56A | 13.17 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_B_DSFB319_1 (GLR4197 PROTEIN) | 5e6j | UBIQUITIN (syntheticconstruct) | 5 / 9 | ILE E 30ILE E 36VAL E 5THR E 7ILE E 13 | 1.48A | 12.54 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_D_DSFD319_1 (GLR4197 PROTEIN) | 5e6j | UBIQUITIN (syntheticconstruct) | 5 / 10 | ILE E 30ILE E 36VAL E 5THR E 7ILE E 13 | 1.48A | 12.54 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_D_DSFD319_1 (GLR4197 PROTEIN) | 5nfy | POLYPROTEIN 1AB (SARS-COVFrankfurt1) | 5 / 10 | PRO P 23TYR P 76ILE P 81VAL P 108ILE P 38 | 1.70A | 16.09 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_B_DSFB319_1 (GLR4197 PROTEIN) | 5nfy | POLYPROTEIN 1AB (SARS-COVFrankfurt1) | 5 / 9 | PRO P 23TYR P 76ILE P 81VAL P 108ILE P 38 | 1.71A | 16.09 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_A_DSFA319_1 (GLR4197 PROTEIN) | 5wrg | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 9 | TYR A 410ILE A 397ILE A 405VAL A 496TYR A 481 | 1.60A | 15.47 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_D_DSFD319_1 (GLR4197 PROTEIN) | 5wrg | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 10 | TYR A 410ILE A 397ILE A 405VAL A 496TYR A 481 | 1.60A | 15.47 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_B_DSFB319_1 (GLR4197 PROTEIN) | 5x5b | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 9 | PRO A1051TYR A1029ILE A 891VAL A 893ILE A 702 | 1.49A | 14.88 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_A_DSFA319_1 (GLR4197 PROTEIN) | 5x5b | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 9 | PRO A1051TYR A1029ILE A 891VAL A 893ILE A 702 | 1.49A | 14.88 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_C_DSFC320_1 (GLR4197 PROTEIN) | 5x5b | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 8 | PRO A1051TYR A1029ILE A 891VAL A 893ILE A 702 | 1.49A | 14.88 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_D_DSFD319_1 (GLR4197 PROTEIN) | 5x5b | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 10 | PRO A1051TYR A1029ILE A 891VAL A 893ILE A 702 | 1.49A | 14.88 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_B_DSFB319_1 (GLR4197 PROTEIN) | 5x5c | S PROTEIN (MERS-CoV) | 5 / 9 | PRO B 476TYR B 577THR B 574ILE B 573ILE B 442 | 1.32A | 13.40 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_D_DSFD319_1 (GLR4197 PROTEIN) | 5x5c | S PROTEIN (MERS-CoV) | 5 / 10 | PRO B 476TYR B 577THR B 574ILE B 573ILE B 442 | 1.33A | 13.40 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_A_DSFA319_1 (GLR4197 PROTEIN) | 5x5f | S PROTEIN (MERS-CoV) | 5 / 9 | PRO A 59TYR A 71ILE A 69TYR A 58ILE A 333 | 1.66A | 13.40 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_B_DSFB319_1 (GLR4197 PROTEIN) | 5xlr | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 9 | PRO B1051TYR B1029ILE B 891VAL B 893ILE B 702 | 1.62A | 15.47 | PRO B1051 ( 1.1A)TYR B1029 ( 1.3A)ILE B 891 ( 0.7A)VAL B 893 ( 0.6A)ILE B 702 ( 0.7A) | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_C_DSFC320_1 (GLR4197 PROTEIN) | 5xlr | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 8 | PRO B1051TYR B1029ILE B 891VAL B 893ILE B 702 | 1.62A | 15.47 | PRO B1051 ( 1.1A)TYR B1029 ( 1.3A)ILE B 891 ( 0.7A)VAL B 893 ( 0.6A)ILE B 702 ( 0.7A) | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_A_DSFA319_1 (GLR4197 PROTEIN) | 6acd | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 9 | TYR C 646TYR C 660ILE C 674VAL C 642ILE C 652 | 1.46A | 15.47 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_C_DSFC320_1 (GLR4197 PROTEIN) | 6acd | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 8 | TYR C 646TYR C 660ILE C 674VAL C 642ILE C 652 | 1.47A | 15.47 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_D_DSFD319_1 (GLR4197 PROTEIN) | 6acg | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 10 | TYR A 481ILE A 405VAL A 337TYR A 494ILE A 397 | 1.49A | 15.47 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_B_DSFB319_1 (GLR4197 PROTEIN) | 6acj | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 9 | ILE B1086VAL C1104THR B1098ILE B1097ILE B1096 | 1.52A | 15.47 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_C_DSFC320_1 (GLR4197 PROTEIN) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 8 | PRO C1051TYR C1029ILE C 891VAL C 893ILE C 702 | 1.64A | 14.20 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_A_DSFA319_1 (GLR4197 PROTEIN) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 9 | PRO A1051TYR A1029ILE A 891VAL A 893ILE A 702 | 1.64A | 14.20 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_D_DSFD319_1 (GLR4197 PROTEIN) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 10 | PRO C1051TYR C1029ILE C 891VAL C 893ILE C 702 | 1.63A | 14.20 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_B_DSFB319_1 (GLR4197 PROTEIN) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 9 | PRO B1051TYR B1029ILE B 891VAL B 893ILE B 702 | 1.63A | 14.20 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_B_DSFB319_1 (GLR4197 PROTEIN) | 6crw | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 9 | PRO B1051TYR B1029ILE B 891VAL B 893ILE B 702 | 1.59A | 14.24 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_A_DSFA319_1 (GLR4197 PROTEIN) | 6crw | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 9 | PRO B1051TYR B1029ILE B 891VAL B 893ILE B 702 | 1.59A | 14.24 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_C_DSFC320_1 (GLR4197 PROTEIN) | 6crw | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 4 / 8 | TYR A 410ILE A 397ILE A 405VAL A 496 | 1.02A | 14.24 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_D_DSFD319_1 (GLR4197 PROTEIN) | 6crw | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 10 | PRO B1051TYR B1029ILE B 891VAL B 893ILE B 702 | 1.59A | 14.24 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_D_DSFD319_1 (GLR4197 PROTEIN) | 6jyt | HELICASE (SARSr-CoV) | 5 / 10 | ILE A 545ILE A 512VAL A 496THR A 547ILE A 575 | 1.47A | 21.04 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_B_DSFB319_1 (GLR4197 PROTEIN) | 6jyt | HELICASE (SARSr-CoV) | 5 / 9 | ILE A 545ILE A 512VAL A 496THR A 547ILE A 575 | 1.50A | 21.04 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_C_DSFC320_1 (GLR4197 PROTEIN) | 6kl2 | NUCLEOPROTEIN (MERS-CoV) | 4 / 8 | TYR A 44PRO A 64THR A 148ILE A 162 | 1.50A | 17.70 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_C_DSFC320_1 (GLR4197 PROTEIN) | 6nb6 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 8 | TYR A 410ILE A 397ILE A 405VAL A 496 | 0.94A | 13.97 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_B_DSFB319_1 (GLR4197 PROTEIN) | 6nb6 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 9 | PRO B1051TYR B1029ILE B 891VAL B 893ILE B 702 | 1.63A | 13.97 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_A_DSFA319_1 (GLR4197 PROTEIN) | 6nb6 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 9 | TYR A 410ILE A 397ILE A 405VAL A 496TYR A 481 | 1.62A | 13.97 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_D_DSFD319_1 (GLR4197 PROTEIN) | 6nb6 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 10 | TYR A 410ILE A 397ILE A 405VAL A 496TYR A 481 | 1.63A | 13.97 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_B_DSFB319_1 (GLR4197 PROTEIN) | 6nus | NSP12NSP8 (SARSr-CoV) | 5 / 9 | PRO B 121ILE B 119VAL A 341ILE B 106ILE B 107 | 1.53A | 21.88 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_D_DSFD319_1 (GLR4197 PROTEIN) | 6nus | NSP12NSP8 (SARSr-CoV) | 5 / 10 | PRO B 121ILE B 119VAL A 341ILE B 106ILE B 107 | 1.53A | 21.88 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_C_DSFC320_1 (GLR4197 PROTEIN) | 6vw1 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 8 | TYR E 423ILE E 410ILE E 418VAL E 510 | 1.06A | 19.17 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_C_DSFC320_1 (GLR4197 PROTEIN) | 6w41 | CR3022 FAB HEAVYCHAIN (Homosapiens) | 4 / 8 | PRO H 52ILE H 34ILE H 50ILE H 69 | 1.77A | 20.14 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_C_DSFC320_1 (GLR4197 PROTEIN) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 4 / 8 | TYR B 27PRO L 65ILE L 81ILE L 54 | 1.20A | None | |||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P4W_C_DSFC320_1 (GLR4197 PROTEIN) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 4 / 8 | TYR H 27PRO C 65ILE C 81ILE C 54 | 1.20A | None |